失去miR-29a/b1集群会重新编程瘤微环境,并导致肺癌免疫抑制
Natalie K Horvat1, Myritney Saint-Cloud2, Raihaanah Bint Abdullah Muslim1
1Emory University Atlanta, GA United States.
Cancer immunology research
|February 25, 2026
概括
肺癌中的microRNA miR-29损失与免疫检查点抑制剂 (ICI) 的耐药性相关. 恢复miR-29通过调节瘤微环境并增强抗瘤免疫力,重新使瘤对ICI敏感.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 针对PD-1/PD-L1的免疫检查点抑制剂 (ICI) 已经改变了非小细胞肺癌 (NSCLC) 治疗.
- 对ICI的治疗耐药性仍然是一个重大的临床挑战,需要确定新的耐药性机制和治疗点.
研究的目的:
- 在Kras/p53驱动的肺癌模型中研究ICI获得或内在耐药性的分子机制.
- 在ICI耐药性的背景下,确定瘤存活和免疫逃避的关键调节者.
主要方法:
- 单细胞RNA测序用于抗PD-1疗法耐药的肺癌模型.
- 生物信息分析专注于识别恶性细胞中差异表达基因的上游调节者.
- 进行了microRNA-29 (miR-29) 和其目标,包括Enpp2/ATX的表达分析.
- 功能性研究包括在耐药模型中重新表达miR-29以及对瘤微环境的分析.
主要成果:
- 在抗PD-1疗法耐药的瘤中观察到miR-29的下调,与miR-29标的上调相关.
- 失去miR-29与免疫抑制酶Enpp2/ATX的表达增加相关.
- 在耐药模型中,miR-29的重新表达减少了ATX,减少了纤维化,增加了CD8+T细胞透.
- 这些miR-29介导的变化通过增强抗瘤免疫力和改变免疫细胞群体,促进了ICI反应.
结论:
- 在肺癌中,miR-29家族在调节瘤微环境和免疫反应方面发挥着至关重要的作用.
- miR-29控制ATX的表达,影响ICI的敏感性.
- 准miR-29或其下游通路可能是克服肺腺癌ICI耐药性的可行策略.
相关概念视频
01:12Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
01:22MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
01:22MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K